Murdoch's poison pill

News Corp will soon be splitting itself in to two separate companies.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Breaking up is hard to do. Sometimes one side isn't quite ready to see the other move on. News Corp (ASX: NWS) will soon be splitting itself in to two separate companies. The publishing operations will keep the 'News Corp' name, while the cable television channels and film studio will form a new company under the name '21st Century Fox'. But despite the split, the existing management team have made it clear that they aren't willing to risk the company falling into the hands of another.

Rupert Murdoch, the executive chairman of News Corp, has during the past week been defending the company's adoption of a 'poison pill' provision. In the Australian leg of an investor road show, he commented "I know it's uncommon in this country, but it's very common in America in these situations".

A 'poison pill' is a defence mechanism put in place to ward off a hostile takeover.  Much like a classic spy movie where the secret agent chomps down on a cyanide tablet before he can be interrogated, its purpose is to prevent capture by enemy forces. Also known as a 'shareholder rights plan', the typical structure gives existing shareholders the right to buy new shares at a discount if a takeover event is triggered, thereby diluting the stake of the would-be acquirer.

News Corp's split comes as the publishing industry undertakes a major transition from print to online. News Corp's largest Australian rival, Fairfax Media (ASX: FXJ), also announced significant restructuring this past week aimed at cutting a further $60 million of costs, and will be joining News Corp in erecting a 'paywall' around its online content.

News Corp's new provision is set to last one year. It will allow existing shareholders to buy stock at a 50% discount, and is triggered if any new investor were to buy 15% or more of the company's Class B voting shares. The immediate dilution would make it very difficult for any potential suitor to build a significant stake in the company.

Poison pills are often bad medicine for small shareholders. Existing managers have less threat of being replaced by a new majority owner, regardless of their performance. They can also stop shareholders from getting a chance to vote on good takeover offers. At their best, they can prevent a predatory takeover before a company is able to fully achieve its vision. In this case it may help buy some precious time for the changes necessary at News Corp to take place.

Foolish takeaway

Although less common in Australia, investors should be cautious of any company looking to create a new 'poison pill' provision. Despite being sold to shareholders as protection against predatory takeovers, they are instead often used to protect underperforming management teams. News Corp shareholders will be hoping that the company can use the security of its 'poison pill' to make the tough choices necessary for its publishing operations to prosper in the online world.

Searching for the stability of a solid dividend payer? Get "3 Stocks for the Great Dividend Boom" in our special FREE report. Click here now to find out the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading

Motley Fool contributor Matt Joass does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »